2009, DNA and Protein Expression - Drug Discovery Digest

Codon Digest: CAR-T Therapy for Neuroblastoma

Codon

APRIL 9, 2023

.” This technology could be used to design protein therapeutics that can bind to, and “shut down,” harmful or misfolded proteins in living cells. Thousands of transcription factors — proteins that bind DNA and control gene expression — were studied in human cells. Bergs A.C.F.

Therapies

Therapies RNA Engineering Vaccine

FDA’s Project Optimus: A new era in oncology drug dosing

Drug Target Review

JANUARY 20, 2025

Genetic factors Mutations or alterations in tumour DNA (eg, EGFR mutations in lung cancer or HER2 amplification in breast cancer) are key targets of precision medicine. Molecular factors Molecular markers, such as protein expression and signalling pathway activation, also guide therapy choices. J., & Jnne, P. Barker, A.

Clinical Trials

Clinical Trials Trials Drugs Drug Development

Drug Discovery Digest

Codon Digest: CAR-T Therapy for Neuroblastoma

FDA’s Project Optimus: A new era in oncology drug dosing

Webinars

Stay Connected